ALPMF - Astellas Pharma Inc. (ALPMY) Kenji Yasukawa on Q2 2020 Results - Earnings Call Transcript

Astellas Pharma Inc. (ALPMY) Q2 2020 Earnings Conference Call October 30, 2020 01:00 AM ET Company Participants Kenji Yasukawa - President & Chief Executive Officer Naoki Okamura - Representative Director & Executive Vice President Yukio Matsui - Chief Commercial Officer Mike Kitagawa - Senior Vice President, Development Project Management Conference Call Participants Hidemaru Yamaguchi – Citigroup Kazuaki Hashiguchi - Daiwa Securities Fumiyoshi Sakai - Credit Suisse Akinori Ueda - Goldman Sachs Shinichiro Muraoka - Morgan Stanley, MUFJ Yo Mizuno - Tokio Marine Asset Management Presentation Kenji Yasukawa Hello, everyone. Yasukawa, speaking. Thank you very much for joining our teleconference, despite your very busy schedule today. First of all, I'd like to talk about our first half results and our initiative for sustainable growth. Page 2 is a usual cautionary statement. I'm not going to read this. Page 3 is the agenda for today. I'm going to start explaining from page

For further details see:

Astellas Pharma Inc. (ALPMY) Kenji Yasukawa on Q2 2020 Results - Earnings Call Transcript